SPOTLIGHT -
Rapid relief, good safety profile, long-term efficacy are advantages for highly effective drugs
Dopavision completes enrollment in trial for the digital treatment of myopia
ROP: Treating and preventing blindness in preterm babies
Orbis International, Siloam Vision unite to save sight of premature infants using artificial intelligence
Managing a changing landscape of IRD pediatric cases
COVID-19 treatment changes infant’s eye color
WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression